Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nicole Azer
Institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research
Observed institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research
ORCID:
0000-0001-9657-7995
Observed ORCID:
0000-0001-9657-7995
OpenAlex ID:
A5048827878
An updated analysis of viral clearance unit operations for biotechnology manufacturing
2022
·
Opeyemi O. Ajayi
, Sarah A. Johnson
, et al.
·
Current Research in Biotechnology
·
33
PDF
An etanercept O-glycovariant with enhanced potency
2022
·
Thomas G. Biel
, Talia Faison
, et al.
·
Molecular Therapy — Methods & Clinical Development
·
22
PDF
Primary Clarification of CHO Harvested Cell Culture Fluid using an Acoustic Separator
2020
·
Jin Sung Hong
, Nicole Azer
, et al.
·
Journal of Visualized Experiments
·
13
PDF
Process development for production of non-originator NISTmAb from CHO and NS0 cell lines
2025
·
Erica J. Fratz-Berilla
, Nicole Azer
, et al.
·
mAbs
·
4
PDF
Real time on‐line amino acid analysis to explore amino acid trends and link to glycosylation outcomes of a model monoclonal antibody
2023
·
Nicole Azer
, Nicholas Trunfio
, et al.
·
Biotechnology Progress
·
3
PDF
NS0 and CHO cell lines generate distinct quality profiles for non‐originator NISTmAbs
2026
·
Xin Bush
, Nicole Azer
, et al.
·
Biotechnology Progress
PDF
Author response for "Real time on‐line amino acid analysis to explore amino acid trends and link to glycosylation outcomes of a model monoclonal antibody"
2023
·
Nicole Azer
, Nicholas Trunfio
, et al.
·
Publons reviews and discussion
Show more works
View as search
Works count:
7
Citation count:
75
H-index:
4
I10-index:
3
Year
Topic
Type